Literature DB >> 5663000

Heredity and malignant melanoma: implications for early cancer detection.

H T Lynch, A J Krush.   

Abstract

Entities:  

Mesh:

Year:  1968        PMID: 5663000      PMCID: PMC1924270     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  10 in total

1.  MALIGNANT MELANOMA OF EYE OCCURRING IN TWO SUCCESSIVE GENERATIONS.

Authors:  S F BOWEN; H BRADY; V L JONES
Journal:  Arch Ophthalmol       Date:  1964-06

2.  ATTITUDES TOWARD CANCER IN A "CANCER FAMILY": IMPLICATIONS FOR CANCER DETECTION.

Authors:  A J KRUSH; H T LYNCH; C MAGNUSON
Journal:  Am J Med Sci       Date:  1965-04       Impact factor: 2.378

3.  Frequency of genetic transmission of sporadic retinoblastoma.

Authors:  D P TUCKER; A G STEINBERG; D G COGAN
Journal:  AMA Arch Ophthalmol       Date:  1957-04

4.  A FAMILY HISTORY OF CHOROIDAL SARCOMA.

Authors:  R C Davenport
Journal:  Br J Ophthalmol       Date:  1927-09       Impact factor: 4.638

5.  A report of malignant melanoma of the skin in sisters.

Authors:  S L MOSCHELLA
Journal:  Arch Dermatol       Date:  1961-12

6.  Genetic aspects of malignant melanoma.

Authors:  E P CAWLEY; W T KRUSE; H K PINKUS
Journal:  AMA Arch Derm Syphilol       Date:  1952-04

7.  Malignant melanomas in twins.

Authors:  I Katzenellenbogen; M Sandbank
Journal:  Arch Dermatol       Date:  1966-09

8.  Heredity and intraocular malignant melanoma. Study of two families and review of forty-five cases.

Authors:  H T Lynch; D E Anderson; A J Krush
Journal:  Cancer       Date:  1968-01       Impact factor: 6.860

9.  Hereditary aspects of malignant melanoma.

Authors:  D E Anderson; J L Smith; C M McBride
Journal:  JAMA       Date:  1967-05-29       Impact factor: 56.272

10.  [Malign melanoma; correlation to pregnancy, childhood, familiar malign melanoma].

Authors:  A GREIFELT
Journal:  Arztl Wochensch       Date:  1952-07-18
  10 in total
  25 in total

Review 1.  Risk factors for intraocular melanoma and occupational exposure.

Authors:  J M Lutz; I A Cree; A J Foss
Journal:  Br J Ophthalmol       Date:  1999-10       Impact factor: 4.638

Review 2.  Update on familial pancreatic cancer.

Authors:  H T Lynch; R E Brand; C A Deters; R M Fusaro
Journal:  Curr Gastroenterol Rep       Date:  2001-04

Review 3.  State of melanoma: an historic overview of a field in transition.

Authors:  Vikram C Gorantla; John M Kirkwood
Journal:  Hematol Oncol Clin North Am       Date:  2014-06       Impact factor: 3.722

4.  Familial malignant melanoma.

Authors:  D C Wallace; G L Beardmore; L A Exton
Journal:  Ann Surg       Date:  1973-01       Impact factor: 12.969

5.  Investigational Strategies for Detection and Intervention in Early-Stage Pancreatic Cancer. April 24-27, Annapolis, Maryland. Abstracts.

Authors: 
Journal:  Int J Pancreatol       Date:  1994 Oct-Dec

Review 6.  Germline mutations predisposing to melanoma.

Authors:  Atrin Toussi; Nicole Mans; Jeanna Welborn; Maija Kiuru
Journal:  J Cutan Pathol       Date:  2020-05-11       Impact factor: 1.587

7.  Multiple primary cutaneous melanomas in patients with FAMMM syndrome and sporadic atypical mole syndrome (AMS): what's worse?

Authors:  Georgi Tchernev; Julian Ananiev; José-Carlos Cardoso; Anastasiya Atanasova Chokoeva; Stanislav Philipov; Plamen Kolev Penev; Torello Lotti; Uwe Wollina
Journal:  Wien Med Wochenschr       Date:  2014-08-06

8.  Primary choroidal and cutaneous melanomas, bilateral choroidal melanomas, and familial occurrence of melanomas.

Authors:  J A Oosterhuis; L N Went; H T Lynch
Journal:  Br J Ophthalmol       Date:  1982-04       Impact factor: 4.638

9.  Familial atypical multiple mole-melanoma (FAMMM) syndrome: segregation analysis.

Authors:  H T Lynch; R M Fusaro; W J Kimberling; J F Lynch; B S Danes
Journal:  J Med Genet       Date:  1983-10       Impact factor: 6.318

10.  Familial atypical multiple mole-melanoma syndrome.

Authors:  H T Lynch; B C Frichot; J F Lynch
Journal:  J Med Genet       Date:  1978-10       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.